Rebastinib (DCC-2036)
-
Catalog numberB1619-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_nameDCC-2036; DCC-2036; DCC2036; Bcr-Abl inhibitor; Bcr-abl inhibitor; 4-[4-[(5-tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
-
DescriptionDCC-2036 (Rebastinib) is an inhibitor of Bcr-Abl with IC50 of 0.8 nM and 4 nM for Abl1(WT) and Abl1(T315I), respectively.
-
CAS Number1020172-07-9
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₃₀H₂₈FN₇O₃
-
Molecular Weight553.59
-
Cell PermeableYes
-
Purity>98%
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA Bcr-Abl inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD19443646
-
PubChem CID25066467
-
SMILESCC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5
-
InChi1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40)
-
InChi KeyWVXNSAVVKYZVOE-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Gene symbolDCC
-
Short nameRebastinib (DCC-2036)
-
Alternative nameRebastinib (deleted in colorectal carcinoma-2036)
-
Alternative to gene targetdeleted in colorectal carcinoma, CRC18 and CRCR1 and IGDCC1 and MRMV1 and NTN1R1, DCC and IDBG-3511 and ENSG00000187323 and 1630, identical protein binding, Plasma membranes, Dcc and IDBG-157336 and ENSMUSG00000060534 and 13176
-
Gene info
-
Identity
-
Gene
-
Long gene nameDCC netrin 1 receptor
-
Synonyms gene name
- deleted in colorectal carcinoma
-
Synonyms
-
Synonyms name
-
GenBank acession
-
Locus
-
Discovery year1990-05-25
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- Fibronectin type III domain containing
- MicroRNA protein coding host genes
- I-set domain containing
-
VEGA ID
-
Locus Specific Databases